Navigation Links
neXante Turns Apple's iPhone Into Skin Cancer Surveillance Support Tool And Health Record
Date:5/19/2010

The neXante Skin Cancer Surveillance Support Suite comprises applications titled xBCC Skin, xSCC Skin, and xMM skin, respectively on Basal Cell Cancer, Squamous Cell Cancer, and Malignant Melanoma of the skin. Each application has neXante's DermTracker, a customized electronic health record that not only tracks and stores images of the skin, but also allows for recording the diagnosis, pathology, and treatment of each skin lesion.

Redmond, WA (Vocus) May 19, 2010 -- Bright 50, a new smartphone healthcare application developer, announced the immediate availability of its neXante Skin Cancer Surveillance Support Suite for Apple Inc's iPhone. With this announcement, consumers and patients gain access to clinical disease modules with the latest clinical studies and consensus medical guidelines integrated with specialized tools to track and monitor a specific disease state.

Skin cancer is the most common cancer in the world, outnumbering all other types of cancer combined. The number of new cases of skin cancer is also rising rapidly, afflicting over 2 million people a year in the United States alone. Of all the cancers, skin cancer has the greatest potential of being cured provided it is recognized and treated early. However, only with effective tools and knowledge can any disease be prevented, recognized, and treated.

The iPhone provides unique benefits and opportunities with its exceptional multimedia capabilities and computational power. Bright 50 has leveraged the capabilities of the iPhone to use as a platform for interactive customizable personalized health tools and records.

The neXante Skin Cancer Surveillance Support Suite comprises applications titled xBCC Skin, xSCC Skin, and xMM skin, respectively on Basal Cell Cancer, Squamous Cell Cancer, and Malignant Melanoma of the skin. Each application has neXante's DermTracker, a customized electronic health record that not only tracks and stores images of the skin, but also allows for recording the diagnosis, pathology, and treatment of each skin lesion.

neXante medical resources enable healthcare consumers to improve the quality of care, reduce costs, increase efficiencies and reduce medical errors while actively engaging individuals to improve their personal health.

About Bright 50

Bright 50 is a healthcare application developer for mobile devices. Bright 50's neXante service educates, enables, and empowers healthcare consumers to become engaged in their health by delivering medical information in an intuitive and interactive manner that supports individual engagement. Bright 50 is a privately held company headquartered in Redmond, Washington. For more information on neXante services go to http://www.nexante.com/. Media contact:pr(at)nexante(dot)com.

###

Read the full story at http://www.prweb.com/releases/nexante/iPhoneSkinCancerApps/prweb4020764.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. The Love Convention Returns With "Something New" at Hotel Arista on Valentines Weekend
2. Identified: Switch that turns on allergic disease in people
3. Biggest Loser Contestant Turns to PlasticSurgeryPortal Doctor to Complete Makeover
4. Movie Turns Into a Growing Movement to Reach Hurting Teens.
5. Effort to Regenerate Injured Spinal Cords Turns to a New Model
6. PACE Race Returns with Denver's Rudolph Ramble
7. 18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact
8. Panel Intelligence Returns to MedPanel Name
9. Wheelchairs for Warriors Returns for 2010 Gasparilla Marathon
10. Former Bank Negotiator Turns On Bank and is Approved by the Department of Real Estate
11. Manduka Turns up the Heat With Introduction of eQua(TM) Hot Yoga Towel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located ... training and leads programs. , In February, 2017, Empower Brokerage introduced their new ... Partners is designed to teach how to maximize their sales efforts, as well ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: ... events will interrelate. “End Time GPS” is the creation of published author, Wesley ... while working on military munitions and space-vehicle projects. Now, at age ninety-one, he shares ...
(Date:3/24/2017)... ... ... Adventures of Joey, The Dog Who Barks at Puddles”: a boisterous story about a ... God intended. “The Adventures of Joey, The Dog Who Barks at Puddles” is the ... writing, especially about truth and human behavior. , Published by Christian Faith Publishing, Patti ...
(Date:3/23/2017)... Texas (PRWEB) , ... March 23, 2017 , ... The ... 3rd location in the greater Houston Area. The new location is located at 2255 ... Luke’s Hospital in Springwoods Village. This newest location will provide patients living in the ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Center at 10 North Broadway Avenue, will be an educational and exciting program ... instruction in the management of chronic pain. , Oklahoma is in a healthcare ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets ... the U.S.: Consumer Strategies" report to their offering. ... Pain ... approach and treat their physical pain, emphasizing consumer survey analysis, ... pain sufferers and adults who have selected illnesses/conditions strongly associated ...
(Date:3/24/2017)... , March 24, 2017 ShangPharma, ... high-quality and cost-effective drug development and discovery ... and biotechnology industry, announced today the intent ... ShangPharma will be consolidating the Contract Research ... under Shanghai ChemPartner. These entities include ChemPartner ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a ... Merck & Co., Inc., Biogen and Sanofi are involved in the development ... of which one is in Phase III stage, 15 are in Phase ...
Breaking Medicine Technology: